545 related articles for article (PubMed ID: 21060341)
1. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Nat Rev Neurol; 2010 Dec; 6(12):657-66. PubMed ID: 21060341
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neuropathy in the adult.
Saad M; Tafani C; Psimaras D; Ricard D
Curr Opin Oncol; 2014 Nov; 26(6):634-41. PubMed ID: 25229554
[TBL] [Abstract][Full Text] [Related]
3. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy-induced Peripheral Neuropathy].
Bobylev I; Elter T; Schneider C; Wunderlich G; Zimmer P; Streckmann F; Fink GR; Lehmann HC
Fortschr Neurol Psychiatr; 2015 Aug; 83(8):427-36. PubMed ID: 26327474
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
[TBL] [Abstract][Full Text] [Related]
7. Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN).
Hertz DL; Childs DS; Park SB; Faithfull S; Ke Y; Ali NT; McGlown SM; Chan A; Grech LB; Loprinzi CL; Ruddy KJ; Lustberg M
Cancer Treat Rev; 2021 Sep; 99():102241. PubMed ID: 34174668
[TBL] [Abstract][Full Text] [Related]
8. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
Knoerl R; Weller E; Halpenny B; Berry D
BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
[TBL] [Abstract][Full Text] [Related]
9. Pain in chemotherapy-induced peripheral neurotoxicity.
Marmiroli P; Scuteri A; Cornblath DR; Cavaletti G
J Peripher Nerv Syst; 2017 Sep; 22(3):156-161. PubMed ID: 28600844
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced peripheral neuropathy: A current review.
Staff NP; Grisold A; Grisold W; Windebank AJ
Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
[TBL] [Abstract][Full Text] [Related]
11. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
12. Vinca alkaloids, thalidomide and eribulin-induced peripheral neurotoxicity: From pathogenesis to treatment.
Islam B; Lustberg M; Staff NP; Kolb N; Alberti P; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S63-S73. PubMed ID: 31647152
[TBL] [Abstract][Full Text] [Related]
13. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue.
Cavaletti G; Alberti P; Argyriou AA; Lustberg M; Staff NP; Tamburin S;
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S6-S12. PubMed ID: 31647155
[TBL] [Abstract][Full Text] [Related]
15. Management options for established chemotherapy-induced peripheral neuropathy.
Pachman DR; Watson JC; Lustberg MB; Wagner-Johnston ND; Chan A; Broadfield L; Cheung YT; Steer C; Storey DJ; Chandwani KD; Paice J; Jean-Pierre P; Oh J; Kamath J; Fallon M; Strik H; Koeppen S; Loprinzi CL
Support Care Cancer; 2014 Aug; 22(8):2281-95. PubMed ID: 24879391
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
[TBL] [Abstract][Full Text] [Related]
17. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
Cavaletti G; Frigeni B; Lanzani F; Mattavelli L; Susani E; Alberti P; Cortinovis D; Bidoli P
Eur J Cancer; 2010 Feb; 46(3):479-94. PubMed ID: 20045310
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models.
Eldridge S; Guo L; Hamre J
Toxicol Pathol; 2020 Jan; 48(1):190-201. PubMed ID: 31331249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
